Comment
doi: 10.1016/j.cjca.2018.03.016.
Epub 2018 Mar 31.
Stroke Prevention for High-Risk Atrial Fibrillation in the Emergency Setting: Differences Between Canada and the United States
- PMID: 29960621
- PMCID: PMC6279238
- DOI: 10.1016/j.cjca.2018.03.016
Item in Clipboard
Comment
Stroke Prevention for High-Risk Atrial Fibrillation in the Emergency Setting: Differences Between Canada and the United States
Can J Cardiol.
2018 Jul.
No abstract available
Conflict of interest statement
Disclosures
The authors have no conflicts of interest to disclose.
Comment in
-
Reply to Kea et al.-Stroke Prevention for High-Risk Atrial Fibrillation in the Emergency Setting: Differences Between Canada and the US.Can J Cardiol. 2018 Jul;34(7):945.e5. doi: 10.1016/j.cjca.2018.04.013. Epub 2018 Apr 14. Can J Cardiol. 2018. PMID: 29960622 No abstract available.
Comment on
-
Stroke Prevention for High-Risk Atrial Fibrillation in the Emergency Setting: The Emergency Physician Perspective.Can J Cardiol. 2018 Feb;34(2):125-131. doi: 10.1016/j.cjca.2017.11.009. Epub 2017 Nov 22. Can J Cardiol. 2018. PMID: 29407006 Review.
Similar articles
-
Reply to Kea et al.-Stroke Prevention for High-Risk Atrial Fibrillation in the Emergency Setting: Differences Between Canada and the US.Can J Cardiol. 2018 Jul;34(7):945.e5. doi: 10.1016/j.cjca.2018.04.013. Epub 2018 Apr 14. Can J Cardiol. 2018. PMID: 29960622 No abstract available.
-
Warfarin in atrial fibrillation patients with moderate chronic kidney disease.Clin J Am Soc Nephrol. 2011 Nov;6(11):2599-604. doi: 10.2215/CJN.02400311. Epub 2011 Sep 8. Clin J Am Soc Nephrol. 2011. PMID: 21903982 Free PMC article. Clinical Trial.
-
Ximelagatran or warfarin for stroke prevention in patients with atrial fibrillation?Stroke. 2004 Feb;35(2):389-91. doi: 10.1161/01.STR.0000115528.53718.1B. Stroke. 2004. PMID: 14757889 Clinical Trial. No abstract available.
-
Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.Circulation. 2018 Oct 2;138(14):1402-1411. doi: 10.1161/CIRCULATIONAHA.117.031457. Circulation. 2018. PMID: 29794081
-
Randomized controlled trials of new oral anticoagulants for stroke prevention in atrial fibrillation.Curr Opin Cardiol. 2012 Jul;27(4):331-9. doi: 10.1097/HCO.0b013e3283540857. Curr Opin Cardiol. 2012. PMID: 22573171 Review.
Cited by
-
Predictors of Acute Atrial Fibrillation and Flutter Hospitalization across 7 U.S. Emergency Departments: A Prospective Study.J Atr Fibrillation. 2021 Feb 28;13(5):2355. doi: 10.4022/jafib.2355. eCollection 2021 Feb-Mar. J Atr Fibrillation. 2021. PMID: 34950330 Free PMC article.
References
-
- Atzema CL. Stroke prevention for high-risk atrial fibrillation in the emergency setting: the emergency physician perspective. Can J Cardiol 2018;34:125–31. - PubMed
-
- Kea B, Robinson C, Zhu A, Livingston J, Sun B. Barriers to prescribing stroke prophylaxis for atrial fibrillation in the emergency department: a qualitative provider perspective [abstract]. Ann Emerg Med 2017;70:S119. - PubMed
-
- Stiell IG, Macle L. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: management of recent-onset atrial fibrillation and flutter in the emergency department. Can J Cardiol 2011;27:38–46. - PubMed
-
- Vinson DR, Warton EM, Mark DG, et al. Thromboprophylaxis for patients with high-risk atrial fibrillation and flutter discharged from the emergency department. West J Emerg Med 2018;19:346–60. https://doi.org/10.1016/j.cjca.2018.03.016 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
